INDIANAPOLIS, Aug. 23, 2017 -- Founded in the year 2000, by Dr. Chuck Dietzen, a Pediatric Physical Medicine and Rehabilitation Specialist and Founder of Timmy Global Health and Michael Hall, a Software Developer who developed large scale software solutions for fortune 500 companies, iSalus Healthcare has grown into much more than a software platform for healthcare practice management and Electronic Health Records.
Though iSalus Healthcare is proud of being named to the 2017 Inc. 5000 list, they get much more satisfaction from the impact they are making in the healthcare space as they partner with practices across the United States. Over the years, iSalus has expand the services they offer in order to truly impact the quality of care their clients are able to provide to the patients they serve.
“In the past few years, we realized that we wanted iSalus to be much more than a technology company. We began to discover that our true passion was connected to having an actual impact on the delivery and quality of care. So much so, that we’ve entered the space ourselves by building new divisions such as ProfitableMD. These services actually impact patients' lives, and the way that providers can deliver care and better overall health outcomes.”
- Michael Hall, Co-Founder, CEO
ProfitableMD is a division of iSalus Healthcare that offers providers the option to outsource Chronic Care Management services to a high-quality partner that not only improves the quality of lives their patients with multiple chronic diseases experience, but also adds value to the providers' practice through improved quality scores and stronger financial performance.
“We are in a unique position to disrupt the industry. Our core product lines had deep roots in a couple specific specialties above others. BehavioralChoice was developed specifically for mental health clinicians that struggled with ease-of-use and trouble with prior authorizations. Clinicians in this field were also in need of something affordable for when they were first starting out. UroChoice was developed to answer the needs of an all-in-one solution that was able to handle the busy work loads that urologists face, while expanding the services they can offer, including Chronic Care Management and Telehealth.”
- Blake Head, VP of Product Development
Both BehavioralChoice, and UroChoice were developed to answer the needs of specific specialists who were still struggling to find software that could help their practice be successful.
About iSalus Healthcare
iSalus Healthcare is headquartered in Indianapolis and provides industry-leading Electronic Health Records (EHR), Practice Management and Medical Billing Services and many other services to thousands of clinicians across the United States. We’ve made it our mission to help physicians increase their efficiency through technology so they can spend more time focusing on patient care while continuing to grow their practice and maximize profitability. For more information, visit isalushealthcare.com.
Renae Rossow iSalus Healthcare 513-600-3124 [email protected]


Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 



